UniProt ID | RXRA_HUMAN | |
---|---|---|
UniProt AC | P19793 | |
Protein Name | Retinoic acid receptor RXR-alpha | |
Gene Name | RXRA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 462 | |
Subcellular Localization | Nucleus . | |
Protein Description | Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.. | |
Protein Sequence | MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLIDKRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Sumoylation | ----MDTKHFLPLDF ----CCCCCCCCCCC | 28.26 | 28112733 | |
12 | Phosphorylation | HFLPLDFSTQVNSSL CCCCCCCCCCCCCCC | 20.00 | 23090842 | |
13 | Phosphorylation | FLPLDFSTQVNSSLT CCCCCCCCCCCCCCC | 36.21 | 23663014 | |
17 | Phosphorylation | DFSTQVNSSLTSPTG CCCCCCCCCCCCCCC | 28.06 | 23663014 | |
18 | Phosphorylation | FSTQVNSSLTSPTGR CCCCCCCCCCCCCCC | 30.39 | 23663014 | |
20 | Phosphorylation | TQVNSSLTSPTGRGS CCCCCCCCCCCCCCC | 34.31 | 30266825 | |
21 | Phosphorylation | QVNSSLTSPTGRGSM CCCCCCCCCCCCCCC | 26.26 | 30266825 | |
23 | Phosphorylation | NSSLTSPTGRGSMAA CCCCCCCCCCCCCCC | 39.00 | 30266825 | |
27 | Phosphorylation | TSPTGRGSMAAPSLH CCCCCCCCCCCCCCC | 12.14 | 11162439 | |
32 | Phosphorylation | RGSMAAPSLHPSLGP CCCCCCCCCCCCCCC | 34.28 | 16184197 | |
49 | Phosphorylation | GSPGQLHSPISTLSS CCCCCCCCCCHHCCC | 32.30 | - | |
56 | Phosphorylation | SPISTLSSPINGMGP CCCHHCCCCCCCCCC | 32.67 | - | |
66 | Phosphorylation | NGMGPPFSVISSPMG CCCCCCCEEEECCCC | 25.06 | - | |
70 | Phosphorylation | PPFSVISSPMGPHSM CCCEEEECCCCCCCC | 14.05 | - | |
78 | Phosphorylation | PMGPHSMSVPTTPTL CCCCCCCCCCCCCCC | 28.14 | - | |
82 | Phosphorylation | HSMSVPTTPTLGFST CCCCCCCCCCCCCCC | 14.27 | 20432439 | |
108 | Sumoylation | VSSSEDIKPPLGLNG CCCCCCCCCCCCCCC | 53.56 | 16912044 | |
108 | Sumoylation | VSSSEDIKPPLGLNG CCCCCCCCCCCCCCC | 53.56 | - | |
124 | Phosphorylation | LKVPAHPSGNMASFT EEECCCCCCCHHHHH | 32.69 | 28555341 | |
129 | Phosphorylation | HPSGNMASFTKHICA CCCCCHHHHHHEEEH | 23.76 | 23917254 | |
145 | Acetylation | CGDRSSGKHYGVYSC CCCCCCCCEEEEEEC | 35.28 | 17761950 | |
147 | Phosphorylation | DRSSGKHYGVYSCEG CCCCCCEEEEEECCC | 16.27 | - | |
150 | Phosphorylation | SGKHYGVYSCEGCKG CCCEEEEEECCCCCC | 11.84 | 28152594 | |
151 | Phosphorylation | GKHYGVYSCEGCKGF CCEEEEEECCCCCCH | 11.86 | 28152594 | |
222 | Phosphorylation | RNENEVESTSSANED CCCCCCCCCCCCCCC | 38.47 | 20873877 | |
223 | Phosphorylation | NENEVESTSSANEDM CCCCCCCCCCCCCCC | 17.13 | 20873877 | |
224 | Phosphorylation | ENEVESTSSANEDMP CCCCCCCCCCCCCCC | 36.41 | 20873877 | |
225 | Phosphorylation | NEVESTSSANEDMPV CCCCCCCCCCCCCCH | 34.89 | 20873877 | |
246 | Phosphorylation | ELAVEPKTETYVEAN EEECCCCCCEEEEEC | 44.25 | 29449344 | |
248 | Phosphorylation | AVEPKTETYVEANMG ECCCCCCEEEEECCC | 37.79 | 29449344 | |
249 | Phosphorylation | VEPKTETYVEANMGL CCCCCCEEEEECCCC | 7.05 | 20432439 | |
259 | Phosphorylation | ANMGLNPSSPNDPVT ECCCCCCCCCCCHHH | 58.30 | 26657352 | |
259 | Ubiquitination | ANMGLNPSSPNDPVT ECCCCCCCCCCCHHH | 58.30 | - | |
260 | Phosphorylation | NMGLNPSSPNDPVTN CCCCCCCCCCCHHHH | 29.04 | 30278072 | |
266 | Phosphorylation | SSPNDPVTNICQAAD CCCCCHHHHHHHHHH | 25.01 | 28450419 | |
267 | Ubiquitination | SPNDPVTNICQAADK CCCCHHHHHHHHHHH | 33.02 | - | |
320 | Ubiquitination | FSHRSIAVKDGILLA CCCCCEEEECCEEEE | 5.75 | - | |
356 | Ubiquitination | VLTELVSKMRDMQMD HHHHHHHHHHHCCCC | 30.40 | - | |
364 | Ubiquitination | MRDMQMDKTELGCLR HHHCCCCHHHHHCEE | 38.26 | - | |
397 | Phosphorylation | EALREKVYASLEAYC HHHHHHHHHHHHHHH | 11.09 | - | |
403 | Phosphorylation | VYASLEAYCKHKYPE HHHHHHHHHHCCCCC | 7.83 | - | |
417 | Ubiquitination | EQPGRFAKLLLRLPA CCCCHHHHHHHHHHH | 36.63 | - | |
417 | Acetylation | EQPGRFAKLLLRLPA CCCCHHHHHHHHHHH | 36.63 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
27 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
49 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
56 | S | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
56 | S | Phosphorylation | Kinase | MAPK9 | P45984 | Uniprot |
66 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
70 | S | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
70 | S | Phosphorylation | Kinase | MAPK9 | P45984 | Uniprot |
78 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
82 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
82 | T | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
82 | T | Phosphorylation | Kinase | MAPK9 | P45984 | Uniprot |
82 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
249 | Y | Phosphorylation | Kinase | MAP2K4 | P45985 | GPS |
260 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
260 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
260 | S | Phosphorylation | Kinase | JNK2 | P45984 | PSP |
260 | S | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
260 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
260 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RXRA_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"Serine 27, a human retinoid X receptor alpha residue, phosphorylatedby protein kinase A is essential for cyclicAMP-mediated downregulationof RXRalpha function."; Harish S., Ashok M.S., Khanam T., Rangarajan P.N.; Biochem. Biophys. Res. Commun. 279:853-857(2000). Cited for: PHOSPHORYLATION AT SER-27, FUNCTION, AND MUTAGENESIS OF SER-27. | |
Sumoylation | |
Reference | PubMed |
"Negative modulation of RXRalpha transcriptional activity by smallubiquitin-related modifier (SUMO) modification and its reversal bySUMO-specific protease SUSP1."; Choi S.J., Chung S.S., Rho E.J., Lee H.W., Lee M.H., Choi H.S.,Seol J.H., Baek S.H., Bang O.S., Chung C.H.; J. Biol. Chem. 281:30669-30677(2006). Cited for: SUMOYLATION AT LYS-108, AND INTERACTION WITH SENP6. |